Reporting owner · CIK 0001754154

Giacobello Scott M.

Visual SEC Form 4 history across 2 companies, 8 transactions and 3 filings.

CFOCHIEF FINANCIAL OFFICERWhitehawk Therapeutics, Inc.
Open-market mix
Filings3Form 4 records
Buying$00 purchases
Selling$6.6K1 sales
Net value−$6.6KBuys minus sells
Companies23 securities
Most recentSep 15, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Mar 25Apr 26Sep 26

Net value flow

Buys minus sells

Mar 25
−$6.6K
Apr 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$6.6K
Median P/S size$6.6K
Direct8
Indirect0
Sep 15, 2026grant

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Aadi Bioscience, Inc. on Mar 03, 2025 valued at $6,594.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Aadi Bioscience, Inc. on Mar 03, 2025 valued at $6,594.

Review SEC filing

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Giacobello Scott M. transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#225859WHWKGiacobello Scott M.
CFO
grant118k$0A09/1809/15
#225858WHWKGiacobello Scott M.
CFO
grant118k$0A09/1809/15
#221095WHWKGiacobello Scott M.
CFO
grant300k$0A04/0304/01
#221094WHWKGiacobello Scott M.
CFO
exercise473k$0M04/0304/01
#221093WHWKGiacobello Scott M.
CFO
exercise473kM04/0304/01
#163937AADIGiacobello Scott M.
CFO
exercise6.75k$0M03/04/202503/01/2025
#163936AADIGiacobello Scott M.
CFO
sale2.80k-$659kS03/04/202503/03/2025
#163935AADIGiacobello Scott M.
CFO
exercise6.75kM03/04/202503/01/2025

Giacobello Scott M. Insider Activity FAQ

SEC Form 4 context

Who is Giacobello Scott M.?

Giacobello Scott M. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001754154.

Which companies has Giacobello Scott M. reported transactions for?

Whitehawk Therapeutics, Inc., Aadi Bioscience, Inc.

When was Giacobello Scott M.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Giacobello Scott M.'s latest insider sale?

sale at Aadi Bioscience, Inc. on Mar 03, 2025 valued at $6,594.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.